Prognostic value of inflammatory and nutritional indexes among advanced NSCLC patients receiving PD‐1 inhibitor therapy

Though immunotherapy has to some extent improved the prognosis of patients with advanced non‐small cell lung cancer (NSCLC), only a few patients benefit. Furthermore, immunotherapy efficacy is affected by inflammatory and nutritional status of patients. To investigate whether dynamics of inflammator...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Qiyu, Yu, Jia, Li, Wei, Luo, Jie, Deng, Qinfang, Chen, Bin, He, Yayi, Zhang, Jie, Zhou, Caicun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107359/
https://www.ncbi.nlm.nih.gov/pubmed/36419356
http://dx.doi.org/10.1111/1440-1681.13740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107359/
https://www.ncbi.nlm.nih.gov/pubmed/36419356
http://dx.doi.org/10.1111/1440-1681.13740

Ejemplares similares